Responses
Inflammatory bowel disease
Original article
Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)
Compose a Response to This Article
Other responses
No responses have been published for this article.